Clinical Trials List
2017-06-15 - 2025-12-31
Phase III
Terminated4
ICD-10C61
Malignant neoplasm of prostate
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chuan-Shu Chen Division of Urology
- 蔡世傳 Division of Urology
- Cheng-Kuang Yang Division of Urology
- Jian-Ri Li Division of Urology
- 熊小澐 Division of Urology
- 裘坤元 Division of Urology
- Chia-Yen Lin Division of Urology
- Cheng-Che Chen Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳冠亨 Division of Urology
- Chi-Rei Yang Division of Urology
- Yi-Huei Chang Division of Urology
- Che-Hung Lin Division of Hematology & Oncology
- Po-Fan Hsieh Division of Urology
- Chao-Hsiang Chang Division of Urology
- Su-Peng Yeh Division of Hematology & Oncology
- Po-Jen Hsiao Division of Urology
- Chi-Ping Huang Division of Urology
- Ching-Chan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 黃俊農 Division of Urology
- 耿俊閎 Division of Urology
- Tsung-Yi Huang Division of Urology
- HSIN-LING YIN Division of Others -
- Yung-Chin Lee Division of Urology
- 李政學 Division of Urology
- Hsiang Ying Lee Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
Audit
None
Taiwan National PI
Co-Principal Investigator
- 劉忠一 Division of Urology
- Kai-Jie Yu Division of Hematology & Oncology
- Rita cheng Division of Hematology & Oncology
- 黃成之 Division of Radiology
- Feng-Yuan Liu Division of Nuclear Medicine
- See-Tong Pang Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- 張英勛 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
9 Terminated
Audit
None
Co-Principal Investigator
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
23 participants
-
Global
1100 participants
